AI based system for longitudinal, repeated measure analyses of freely moving C. elegans worms

基于人工智能的系统，用于对自由移动的秀丽隐杆线虫进行纵向、重复测量分析

• 批准号: 10258638
• 负责人: JACOB R GLASER
• 金额: $ 45万
• 依托单位: MICROBRIGHTFIELD, LLC
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-07-09 至 2022-07-08
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10258638
• 关键词: Acetylcholine; Address; Agar; Aging; Alzheimer' s Disease; Animal Behavior; Animal Model; Appearance; Artificial Intelligence; Behavior; Behavioral; Behavioral Research; Biological Assay; Biotechnology; Brain; Brain Diseases; Caenorhabditis elegans; Classification; Collaborations; Complex; Computer software; Data; Development; Disease; Dopamine; Eukaryota; Feasibility Studies; Glutamates; Goals; Human; Image; Individual; Laboratories; Legal patent; Lighting; Locomotion; Longevity; Longitudinal Studies; Market Research; Massachusetts; Measures; Microscope; Molecular; Motion; Mus; Names; National Institute of Mental Health; Nematoda; Neurodegenerative Disorders; Neurodevelopmental Disorder; Neurosciences; Neurotransmitters; Pathologic; Pharmacologic Substance; Phase; Population Analysis; Preparation; Psyche structure; Rattus; Research; Research Design; Research Personnel; Rodent; Schizophrenia; Schools; Serotonin; Speed; Strategic Planning; System; Technology; Testing; Time; Toxicology; Traumatic Brain Injury; Validation; Visual Fields; Work; analytical method; autism spectrum disorder; base; behavioral study; convolutional neural network; design; digital; drug discovery; fighting; free behavior; gamma-Aminobutyric Acid; high throughput screening; innovation; intelligent algorithm; longitudinal analysis; neural network architecture; neurodevelopment; neuropsychiatric disorder; neurotransmitter release; next generation; novel; novel therapeutics; prevent; prototype; receptor; social; usability

Abstract This project aims to develop WormInvestigator™, a novel, highly innovative system for performing automated, high-throughput and longitudinal studies of the behavior of C. elegans worms freely moving and socially interacting on agar plates (hereafter: "freely moving worms") across multiple time points over extended times (e.g., multiple days) with repeated measures designs. Work in Phase I will focus on demonstrating feasibility of our novel, patent pending, WormRecognizer™ technology – the ability to perform automatic, image-based identification of individual C. elegans worms within a group of freely moving worms ("digital tagging of freely moving worms"). Work in Phase II will focus on creating the full functionality of WormInvestigator for the commercial release. The innovation inherent in WormRecognizer will serve as the basis for enabling a game- changing innovation in the field – the ability to perform high throughput longitudinal, repeated measures design analyses of locomotion and other behavior of freely moving C. elegans worms from discrete, non-continuous video sequences. Compared to study designs that have independent groups repeated measures designs offer more statistical power and the possibility to track an effect over time. Specifically, repeated measures designs for analyzing locomotion and other behavior of freely moving worms will allow researchers to definitively assess the likelihood that a particular behavior is associated with a prior behavior, which is impossible without repeated measures designs or impractical continuous imaging and tracking under constant illumination. WormRecognizer will leverage the Deep Convolutional Neural Network (CNN) architecture to perform automatic identification of the tracks of the same worm in videos of groups of freely moving worms recorded at different time points; encouraging pilot data were generated during preparation of this application. C. elegans is increasingly used as a model organism in research focusing on brain mechanisms underlying complex behaviors and pathological alterations thereof, including research into neurodevelopment, Alzheimer's disease, autism, schizophrenia and traumatic brain injury. Thus, WormInvestigator will enable significant advancements in various mental neuroscience applications that use C. elegans as a model organism. Specifically, the fact that C. elegans express many of the neurotransmitters and associated receptors that are found in higher eukaryotes, including humans, makes C. elegans highly attractive for the (high throughput) screening of next generation therapeutics for mental diseases such as Alzheimer's disease, as well as for disorders that rely on neurotransmitter release modulation such as next generation treatments for schizophrenia. We will perform extensive feasibility studies, product validation and usability studies of WormInvestigator in close collaboration with expert neuroscientists. Market research performed during preparation of this application indicated that WormInvestigator will expand the use of C. elegans as a model organism to many laboratories that do not currently use them. A competing technology is not available. We anticipate the global market size for WormInvestigator to be more than 300 systems.

摘要